Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Lumos Diagnostics Holdings Ltd. has announced an accelerated non-renounceable entitlement offer at a discounted issue price to raise approximately A$10 million. The offer is available to eligible shareholders in Australia and New Zealand, with institutional offers already closed and retail shareholder details provided online and via email. The company aims to ease the financial process while adhering to regulatory requirements.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
